Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

• Published in: Cancer cell international Vol. 23; no. 1; p. 137
• Main Authors: Xu, Di, Chen, Wen-Quan, Liang, Ming-Xing, Chen, Xiu, Liu, Zhen, Fei, Yin-Jiao, Shao, Xin-Yi, Wu, Yang, Zhang, Wei, Tang, Jin-Hai
• Format: Journal Article
• Language: English
• Published: England BioMed Central 14.07.2023; BMC
• Subjects: AKT protein; Bioinformatics; Breast cancer; CD163 antigen; Cell culture; Communication; Drug resistance; Extracellular vesicles; Flow cytometry; Immunotherapy; Macrophages; Medical prognosis; Metastases; Metastasis; Microenvironments; MicroRNA; MicroRNAs; miRNA; Next-generation sequencing; PD-L1; PD-L1 protein; PTEN protein; Signal transduction; Small extracellular vesicles; Stains & staining; Stat3 protein; Tumors; United States > US; China; California; PD-L1; Breast cancer; MicroRNA; Small extracellular vesicles; Macrophages
• ISSN: 1475-2867; 1475-2867
• DOI: 10.1186/s12935-023-02980-0

The metastasis of breast cancer (BC) is a complex multi-step pathological process, strictly dependent on the intrinsic characteristics of BC cells and promoted by a predisposing microenvironment. Although immunotherapy has made important progress in metastasis BC, the heterogeneity of PD-L1 in tumor associated macrophages (TAMs) in BC and the underlying mechanisms in the metastasis development of BC are still not completely elucidated. Small extracellular vesicles (sEVs) represent essential interaction mediators between BC cells and TAMs. It is worth noting to explore the underlying mechanisms typical of sEVs and their role in the metastasis development of BC. The structure of sEVs was identified by TEM, while the particle size and amounts of sEVs were detected by BCA and NTA analysis. The specific PD-L1 + CD163 + TAM subpopulation in metastasis BC was identified by scRNA-seq data of GEO datasets and verified by IHC and IF. The function of TAMs and sEVs in metastasis BC was explored by RT-qPCR, WB, IF, flow cytometry and in vivo experiment. The expression profiles of plasma sEVs-miRNA in relation to BC metastasis was analyzed using next-generation sequencing. Further detailed mechanisms of sEVs in the metastasis development of BC were explored by bioinformatics analysis, RT-qPCR, WB and luciferase reporter assay. In this study, we identified that the immunosuppressive molecule PD-L1 was more abundant in TAMs than in BC cells, and a specific PD-L1 + CD163 + TAM subpopulation was found to be associated with metastasis BC. Additionally, we found that BC cells-derived sEVs can upregulate the PD-L1 expression and induce the M2 polarization, enhancing the metastasis development both in vitro and in vivo. Also, Clinical data showed that sEV-miR-106b-5p and sEV-miR-18a-5p was in relation to BC metastasis development and poor prognosis of BC patients. Further mechanistic experiments revealed that BC-derived sEV-miR-106b-5p and sEV-miR-18a-5p could synergistically promoted the PD-L1 expression in M2 TAMs by modulating the PTEN/AKT and PIAS3/STAT3 pathways, resulting in the enhancement of the BC cells invasion and metastasis. Our study demonstrated that BC-derived sEVs can induce metastasis in BC through miR-106b-5p/PTEN/AKT/PD-L1 and miR-18a-5p/PIAS3/STAT3/PD-L1 pathways in TAMs. Therefore, the inhibition of these specific interactions of signaling pathways would represent a promising target for future therapeutic strategies for treatment of BC.